Peptides exist in a regulatory environment that is genuinely complex — and getting more defined every year. This hub cuts through the confusion: what is legal, what the FDA's position actually means, what to look for in a provider, and how to protect yourself from the risks that exist in an industry with significant quality variation.
The short answer is: it depends on the peptide. The longer answer involves FDA approval status, compounding pharmacy rules, research chemical designations, and a regulatory landscape that has been actively reshaping itself since 2020. This guide explains where peptides actually stand under US law.
read more
The FDA's approach to peptides has evolved significantly — from bulk drug substance lists to Category 1 and Category 2 designations to the 2025 labelling changes on hormone therapies. This guide explains the regulatory framework and what FDA status actually means for access, quality, and safety.
read more
One of the most important distinctions in the entire peptide space: the difference between peptides dispensed through licensed compounding pharmacies and peptides sold as "research chemicals." This guide explains the practical, legal, and safety differences between these two categories.
read more
Finding a physician who understands peptide therapy and works with a properly licensed compounding pharmacy is the most important safety step in this space. This guide explains what to look for, what to avoid, and what questions to ask before starting any protocol.
read more
Before committing to any peptide protocol, there is a minimum set of clinical questions that should be answered — about the compound, the source, the physician's qualifications, and the monitoring plan. This guide gives you the complete list.
read more
Peptides are generally well-tolerated — but that doesn't mean side-effect-free. This guide covers the expected and manageable side effects across the major peptide categories, and the specific presentations that should prompt you to stop and contact a clinician.
read more
The peptide market has significant quality problems — from mislabelled compounds to bacterial contamination to vendors operating outside legal frameworks. This guide gives you a concrete checklist of red flags that indicate a peptide source or protocol is unsafe.
read more